Stromal-derived factor (SDF)-1 and its G protein–coupled receptor, CXCR4, regulate stem/progenitor cell migration and retention in the marrow and are required for hematopoiesis. We show here an interaction between CXCR4 and the Src-related kinase, Lyn, in normal progenitors. We demonstrate that CXCR4-dependent stimulation of Lyn is associated with the activation of phosphatidylinositol 3-kinase (PI3-kinase). This chemokine signaling, which involves a Src-related kinase and PI3-kinase, appears to be a target for BCR/ABL, a fusion oncoprotein expressed only in leukemia cells. We show that the binding of phosphorylated BCR/ABL to Lyn results in the constitutive activation of Lyn and PI3-kinase, along with a total loss of responsiveness of these kinases to SDF-1 stimulation. Inhibition of BCR/ABL tyrosine kinase with STI571 restores Lyn responsiveness to SDF-1 signaling. Thus, BCR/ABL perturbs Lyn function through a tyrosine kinase-dependent mechanism. Accordingly, the blockade of Lyn tyrosine kinase inhibits both BCR/ABL-dependent and CXCR4-dependent cell movements. Our results demonstrate, for the first time, that Lyn-mediated pathological crosstalk exists between BCR/ABL and the CXCR4 pathway in leukemia cells, which disrupts chemokine signaling and chemotaxis, and increases the ability of immature cells to escape from the marrow. These results define a Src tyrosine kinases-dependent mechanism whereby BCR/ABL (and potentially other oncoproteins) dysregulates G protein–coupled receptor signaling and function of mammalian precursors.
Skip Nav Destination
Article navigation
2 September 2002
Article|
September 02 2002
Crosstalk Between BCR/ABL Oncoprotein and CXCR4 Signaling through a Src Family Kinase in Human Leukemia Cells
Andrzej Ptasznik,
Andrzej Ptasznik
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Elzbieta Urbanowska,
Elzbieta Urbanowska
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
2Department of Hematology/Oncology and Internal Medicine, Medical University of Warsaw, Warsaw 00-097, Poland
Search for other works by this author on:
Suneetha Chinta,
Suneetha Chinta
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Melinda A. Costa,
Melinda A. Costa
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Benjamin A. Katz,
Benjamin A. Katz
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Marisha A. Stanislaus,
Marisha A. Stanislaus
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Gokhan Demir,
Gokhan Demir
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Diana Linnekin,
Diana Linnekin
3Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute, Frederick, MD 21702
Search for other works by this author on:
Zhixing K. Pan,
Zhixing K. Pan
4Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037
Search for other works by this author on:
Alan M. Gewirtz
Alan M. Gewirtz
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Search for other works by this author on:
Andrzej Ptasznik
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Elzbieta Urbanowska
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
2Department of Hematology/Oncology and Internal Medicine, Medical University of Warsaw, Warsaw 00-097, Poland
Suneetha Chinta
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Melinda A. Costa
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Benjamin A. Katz
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Marisha A. Stanislaus
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Gokhan Demir
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Diana Linnekin
3Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute, Frederick, MD 21702
Zhixing K. Pan
4Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037
Alan M. Gewirtz
1Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
Address correspondence to Andrzej Ptasznik, Hematology/Oncology Division, University of Pennsylvania School of Medicine, BRB-2, Seventh Floor, Rm. 712, 421 Curie Boulevard, Philadelphia, PA 19104-6100. Phone: 215-573-4804; Fax: 215-573-7049. E-mail: [email protected] or Alan M. Gewirtz, Department of Medicine, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104-6100. Phone: 215-573-4804; Fax: 215-573-7049. E-mail: [email protected]
S. Chinta and E. Urbanowska contributed equally to this paper.
*
Abbreviations used in this paper: CML, chronic myelogenous leukemia; PI3-kinase, phosphatidylinositol 3-kinase; SDF, stromal-derived factor.
Received:
April 02 2002
Revision Received:
June 24 2002
Accepted:
July 22 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (5): 667–678.
Article history
Received:
April 02 2002
Revision Received:
June 24 2002
Accepted:
July 22 2002
Citation
Andrzej Ptasznik, Elzbieta Urbanowska, Suneetha Chinta, Melinda A. Costa, Benjamin A. Katz, Marisha A. Stanislaus, Gokhan Demir, Diana Linnekin, Zhixing K. Pan, Alan M. Gewirtz; Crosstalk Between BCR/ABL Oncoprotein and CXCR4 Signaling through a Src Family Kinase in Human Leukemia Cells . J Exp Med 2 September 2002; 196 (5): 667–678. doi: https://doi.org/10.1084/jem.20020519
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement